BACKGROUND AND PURPOSE: Amyloid-β (Aβ), a peptide that accumulates in the brain and circulates in the blood of patients with Alzheimer disease, alters the regulation of cerebral blood flow and may contribute to the brain dysfunction underlying the dementia. However, the contributions of brain and circulating Aβ1-40 to the vascular dysfunction have not been elucidated. METHODS: We used transgenic mice overexpressing mutated forms of the amyloid precursor protein in which Aβ1-40 is elevated in blood and brain (Tg-2576) or only in brain (Tg-SwDI). Mice were equipped with a cranial window, and the increase in cerebral blood flow induced by neural activity (whisker stimulation), or by topical application of endothelium-dependent vasodilators, was assessed by laser-Doppler flowmetry. RESULTS: The cerebrovascular dysfunction was observed also in Tg-SwDI mice, but despite ≈40% higher levels of brain Aβ1-40, the effect was less marked than in Tg-2576 mice. Intravascular administration of Aβ1-40 elevated plasma Aβ1-40 and enhanced the dysfunction in Tg-SwDI mice, but not in Tg-2576 mice. CONCLUSIONS: The results provide evidence that Aβ1-40 acts on distinct luminal and abluminal vascular targets, the deleterious cerebrovascular effects of which are additive. Furthermore, the findings highlight the importance of circulating Aβ1-40 in the cerebrovascular dysfunction and may provide insight into the cerebrovascular alterations in conditions in which elevations in plasma Aβ1-40 occur.
BACKGROUND AND PURPOSE: Amyloid-β (Aβ), a peptide that accumulates in the brain and circulates in the blood of patients with Alzheimer disease, alters the regulation of cerebral blood flow and may contribute to the brain dysfunction underlying the dementia. However, the contributions of brain and circulating Aβ1-40 to the vascular dysfunction have not been elucidated. METHODS: We used transgenic mice overexpressing mutated forms of the amyloid precursor protein in which Aβ1-40 is elevated in blood and brain (Tg-2576) or only in brain (Tg-SwDI). Mice were equipped with a cranial window, and the increase in cerebral blood flow induced by neural activity (whisker stimulation), or by topical application of endothelium-dependent vasodilators, was assessed by laser-Doppler flowmetry. RESULTS: The cerebrovascular dysfunction was observed also in Tg-SwDI mice, but despite ≈40% higher levels of brain Aβ1-40, the effect was less marked than in Tg-2576 mice. Intravascular administration of Aβ1-40 elevated plasma Aβ1-40 and enhanced the dysfunction in Tg-SwDI mice, but not in Tg-2576 mice. CONCLUSIONS: The results provide evidence that Aβ1-40 acts on distinct luminal and abluminal vascular targets, the deleterious cerebrovascular effects of which are additive. Furthermore, the findings highlight the importance of circulating Aβ1-40 in the cerebrovascular dysfunction and may provide insight into the cerebrovascular alterations in conditions in which elevations in plasma Aβ1-40 occur.
Authors: R B DeMattos; K R Bales; D J Cummins; J C Dodart; S M Paul; D M Holtzman Journal: Proc Natl Acad Sci U S A Date: 2001-07-03 Impact factor: 11.205
Authors: John D Fryer; Jennie W Taylor; Ronald B DeMattos; Kelly R Bales; Steven M Paul; Maia Parsadanian; David M Holtzman Journal: J Neurosci Date: 2003-08-27 Impact factor: 6.167
Authors: Reisa A Sperling; Clifford R Jack; Sandra E Black; Matthew P Frosch; Steven M Greenberg; Bradley T Hyman; Philip Scheltens; Maria C Carrillo; William Thies; Martin M Bednar; Ronald S Black; H Robert Brashear; Michael Grundman; Eric R Siemers; Howard H Feldman; Rachel J Schindler Journal: Alzheimers Dement Date: 2011-07 Impact factor: 21.566
Authors: Indra Sethy Coraci; Jens Husemann; Joan W Berman; Christine Hulette; Jennifer H Dufour; Gabriele K Campanella; Andrew D Luster; Samuel C Silverstein; Joseph B El-Khoury Journal: Am J Pathol Date: 2002-01 Impact factor: 4.307
Authors: Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri Journal: Stroke Date: 2011-07-21 Impact factor: 7.914
Authors: Daniel Paris; James Humphrey; Amita Quadros; Nikunj Patel; Robert Crescentini; Fiona Crawford; Michael Mullan Journal: Neurol Res Date: 2003-09 Impact factor: 2.448
Authors: Kiyoshi Niwa; Ken Kazama; Linda Younkin; Steven G Younkin; George A Carlson; Costantino Iadecola Journal: Am J Physiol Heart Circ Physiol Date: 2002-07 Impact factor: 4.733
Authors: Andreas Charidimou; Gregoire Boulouis; M Edip Gurol; Cenk Ayata; Brian J Bacskai; Matthew P Frosch; Anand Viswanathan; Steven M Greenberg Journal: Brain Date: 2017-07-01 Impact factor: 13.501
Authors: Laibaik Park; Kenzo Koizumi; Sleiman El Jamal; Ping Zhou; Mary Lou Previti; William E Van Nostrand; George Carlson; Costantino Iadecola Journal: Stroke Date: 2014-04-29 Impact factor: 7.914
Authors: Kassandra Kisler; Divna Lazic; Melanie D Sweeney; Shane Plunkett; Mirna El Khatib; Sergei A Vinogradov; David A Boas; Sava Sakadži; Berislav V Zlokovic Journal: Nat Protoc Date: 2018-05-24 Impact factor: 13.491
Authors: Maria E Conidi; Livia Bernardi; Gianfranco Puccio; Nicoletta Smirne; Maria G Muraca; Sabrina A M Curcio; Rosanna Colao; Paola Piscopo; Maura Gallo; Maria Anfossi; Francesca Frangipane; Alessandra Clodomiro; Maria Mirabelli; Franca Vasso; Chiara Cupidi; Giusi Torchia; Raffaele Di Lorenzo; Paola Mandich; Annamaria Confaloni; Raffaele G Maletta; Amalia C Bruni Journal: Neurology Date: 2015-05-06 Impact factor: 9.910
Authors: Laibaik Park; Ken Uekawa; Lidia Garcia-Bonilla; Kenzo Koizumi; Michelle Murphy; Rose Pistik; Linda Younkin; Steven Younkin; Ping Zhou; George Carlson; Josef Anrather; Costantino Iadecola Journal: Circ Res Date: 2017-05-17 Impact factor: 17.367